Post job

Seres Therapeutics overview

Industry
Research Institute
Revenue
Headquarters
Employees
145
Founded in
Website
Organization type
Public
Social media
Seres Health is a clinical-stage therapeutics company focused on discovering and developing drugs to treat diseases of the microbiome. The biology of the microbiome is driven by ecologies-the functional collections of various organisms-which are central to health and disease. Seres is developing Ecobiotic™ therapeutics to treat diseases that have an underlying microbiome biology. Our first clinical program is in the treatment of Clostridium difficile infection.
Seres Therapeutics is a small technology company based in Cambridge, MA with only 145 employees and an annual revenue of $144.9M.

Seres Therapeutics's mission statement

To transform the lives of patients worldwide with revolutionary microbiome therapeutics.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Seres Therapeutics employee reviews

Be the first to review!

Do you work at Seres Therapeutics?

Help job seekers learn about working at Seres Therapeutics

On this page

Be the first to review Seres Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Seres Therapeutics?

The team at Seres Therapeutics

  • The founders of Seres Therapeutics are Noubar Afeyan, David Berry and Geoffrey von Maltzahn.
  • The key people at Seres Therapeutics are Eric D. Shaff, Noubar Afeyan and David Berry.
Key people
Eric D. Shaff
Noubar Afeyan
David Berry
Geoffrey von Maltzahn

Seres Therapeutics rankings

Seres Therapeutics is ranked #86 on the Best Technology companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Seres Therapeutics salaries

Average Seres Therapeutics salary
$85,852
yearly
$41.27 hourly
Updated March 14, 2024

Rate Seres Therapeutics' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at Seres Therapeutics?

Were you satisfied with Seres Therapeutics' salary and benefits?

Seres Therapeutics financial performance

9.6
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Seres Therapeutics currently has 7.1M in revenue. Seres Therapeutics's most recent quarter produced 310.0k (q3'2023).

Seres Therapeutics annual revenue

$145M
$116M
$87M
$58M
$29M
$0
2016
2017
2018
2019
2020
2021

Are you an executive, HR leader, or brand manager at Seres Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Seres Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Seres Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Seres Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Seres Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Seres Therapeutics. The data presented on this page does not represent the view of Seres Therapeutics and its employees or that of Zippia.

Seres Therapeutics may also be known as or be related to SERES THERAPEUTICS INC., Seres Therapeutics, Seres Therapeutics Inc and Seres Therapeutics, Inc.